The store will not work correctly when cookies are disabled.
Thieno[2,3-b]pyrrolizin-8-one O-(2-diethylamino-ethyl)-oxime
ID: ALA140105
PubChem CID: 44360712
Max Phase: Preclinical
Molecular Formula: C15H19N3OS
Molecular Weight: 289.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)CCO/N=C1\c2sccc2-n2cccc21
Standard InChI: InChI=1S/C15H19N3OS/c1-3-17(4-2)9-10-19-16-14-12-6-5-8-18(12)13-7-11-20-15(13)14/h5-8,11H,3-4,9-10H2,1-2H3/b16-14-
Standard InChI Key: RMKNXTZRZSDIHT-PEZBUJJGSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
3.9667 -1.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1667 -1.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -0.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0042 -0.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 -2.5292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.9167 -1.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -2.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2750 0.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5250 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8750 -2.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0667 0.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1917 -2.7750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2542 -3.4875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4292 -3.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3500 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9125 -3.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1042 -2.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6667 -3.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 5 1 0
4 2 2 0
5 1 1 0
6 2 1 0
7 4 1 0
8 1 2 0
9 3 1 0
10 5 2 0
11 6 1 0
12 10 1 0
13 8 1 0
14 16 1 0
15 13 1 0
16 15 1 0
17 14 1 0
18 14 1 0
19 17 1 0
20 18 1 0
4 3 1 0
9 12 2 0
11 7 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 289.40 | Molecular Weight (Monoisotopic): 289.1249 | AlogP: 2.96 | #Rotatable Bonds: 6 |
Polar Surface Area: 29.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.38 | CX LogP: 3.37 | CX LogD: 2.36 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.52 | Np Likeness Score: -1.57 |
References
1. Baglin I, Daveu C, Lancelot JC, Bureau R, Dauphin F, Pfeiffer B, Renard P, Delagrange P, Rault S.. (2001) First tricyclic oximino derivatives as 5-HT3 ligands., 11 (4): [PMID:11229746] [10.1016/s0960-894x(00)00691-0] |